XML 72 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-based compensation - Narrative (Details) - USD ($)
1 Months Ended 10 Months Ended 12 Months Ended 34 Months Ended
Aug. 31, 2016
May 31, 2016
Nov. 30, 2015
Dec. 31, 2014
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Sep. 30, 2014
Apr. 30, 2014
Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense       $ 1,462,061 $ 6,572,963 $ 6,597,359        
Shares granted       1,020,234 763,320 994,748        
Shares granted, weighted-average grant date fair value (in usd per share)       $ 2.20 $ 6.35 $ 8.55        
Shares exercised       13,572 8,516 47,280        
Shares exercised, weighted average exercise price (in usd per share)       $ 0.60 $ 2.59 $ 8.63        
Stock options exercised, intrinsic value       $ 51,719 $ 64,302 $ 149,386        
Unrecognized compensation cost         $ 8,668,326   $ 8,668,326      
Unrecognized compensation cost, recognition period         2 years 1 month 10 days          
Non-employee Stock Options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares granted to non-employee consultants and members of the Scientific Advisory Board             272,993      
Stock options, vesting period             4 years      
Stock options, contractual term             10 years      
Stock-based compensation expense       $ 149,000 $ 369,735 $ 517,336        
Options to purchase common stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock options, contractual term         10 years          
Stock-based compensation expense $ 58,000 $ 227,000                
Options to purchase common stock | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock options, vesting period         1 year          
Options to purchase common stock | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock options, vesting period         4 years          
Performance Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares granted     150,000              
Flex Pharma, Inc. 2014 Equity Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares authorized               2,070,200 1,451,087 116,754
Shares remaining available for grant of stock awards         566,323   566,323